AbbVie filed an 8-K reporting a material event related to Allergan Aesthetics, the company's aesthetics division housing Botox and Juvéderm. While the specific details require review of the full filing, material events in this context typically signal pricing adjustments, rebate program changes, or strategic shifts affecting the injectables market.